BioCentury
ARTICLE | Company News

Hemoxymed, Ophidian deal

August 27, 2001 7:00 AM UTC

The companies completed their previously announced reverse merger under which OPHD acquired HemoXymed in exchange for OPHD stock (see BioCentury, Feb. 5). The combined company will retain the HemoXyme...